05/03/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2024
3:21 PM | ACADIA Pharmaceuticals (Filer)
| Form DEF 14A | |
04/15/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
6:58 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:00 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:02 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
6:57 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:07 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:10 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:13 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:08 AM | ACADIA Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
02/09/2024
7:35 AM | ACADIA Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
4:05 PM | ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
4:09 PM | ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
8:55 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
6:37 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
11:46 AM | ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/28/2023
4:32 PM | ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
4:11 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:21 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
4:30 PM | ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
9:00 PM | ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
8:59 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
5:31 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
12:06 PM | ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2023
6:31 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
10:15 AM | ACADIA Pharmaceuticals (Subject)
Schneyer Mark C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2023
5:00 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:01 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
A once-in-a-century investment opportunity (Ad) It's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead. To get its name and ticker symbol for free - just click here. |
07/14/2023
10:33 AM | ACADIA Pharmaceuticals (Subject)
DAVIS STEPHEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023
7:27 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
9:42 AM | ACADIA Pharmaceuticals (Subject)
DAVIS STEPHEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:38 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
10:36 AM | ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023
4:14 PM | ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
7:48 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
1:34 PM | ACADIA Pharmaceuticals (Subject)
Brege Laura (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
8:43 PM | ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:46 PM | ACADIA Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:34 PM | ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:38 PM | ACADIA Pharmaceuticals (Issuer)
Daly James M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:39 PM | ACADIA Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:42 PM | ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:09 PM | 667, L.P. (Reporting)
ACADIA Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:11 PM | ACADIA Pharmaceuticals (Subject)
BAKER BROS. ADVISORS LP (Filed by)
| Form SC 13D/A | |
05/19/2023
5:54 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
5:43 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
5:48 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
